-
1m 7sPart 5 | Session 2 Simon Walsh
-
48sPart 5 | Session 3 Paul Knaapen
-
42sPart 5 | Session 4 Colin Berry
-
56sPart 6 | Session 1 Keith Oldroyd
-
1m 5sPart 6 | Session 2 Simon Walsh
-
1m 3sPart 6 | Session 3 Paul Knaapen
-
49sPart 6 | Session 4 Colin Berry
-
46sPart 7 | Session 1 Keith Oldroyd
-
52sPart 7 | Session 2 Simon Walsh
-
37sPart 7 | Session 3 Paul Knaapen
-
21sPart 7 | Session 4 Colin Berry
-
32sPart 8 | Session 1 Keith Oldroyd
-
35sPart 8 | Session 2 Simon Walsh
-
39sPart 8 | Session 3 Paul Knaapen
-
8sPart 8 | Session 4 Colin Berry
-
54sPart 9 | Session 1 Keith Oldroyd
-
1m 1sPart 9 | Session 2 Simon Walsh
-
58sPart 9 | Session 3 Paul Knaapen
-
1m 8sPart 9 | Session 4 Colin Berry
-
1m 15sPart 10 | Session 1 Keith Oldroyd
-
52sPart 10 | Session 2 Simon Walsh
-
50sPart 10 | Session 3 Paul Knaapen
-
1m 14sPart 10 | Session 4 Colin Berry
-
43sPart 11 | Session 1 Keith Oldroyd
-
39sPart 11 | Session 2 Simon Walsh
-
57sPart 11 | Session 3 Paul Knaapen
-
19sPart 11 | Session 4 Colin Berry
-
57sPart 1 | Session 1 Keith Oldroyd
-
1m 7sPart 1 | Session 2 Simon Walsh
-
1m 8sPart 1 | Session 3 Paul Knaapen
-
53sPart 1 | Session 4 Colin Berry
-
51sPart 2 | Session 1 Keith Oldroyd
-
57sPart 2 | Session 2 Simon Walsh
-
1m 15sPart 2 | Session 3 Paul Knaapen
-
1m 10sPart 2 | Session 4 Colin Berry
-
43sPart 3 | Session 1 Keith Oldroyd
-
1m 14sPart 3 | Session 2 Simon Walsh
-
43sPart 3 | Session 3 Paul Knaapen
-
45sPart 3 | Session 4 Colin Berry
-
49sPart 4 | Session 1 Keith Oldroyd
-
1m 4sPart 4 | Session 2 Simon Walsh
-
1m 4sPart 4 | Session 3 Paul Knaapen
-
1m 12sPart 4 | Session 4 Colin Berry
A short series of 60-second insight videos on Multivessel Disease (MVD).
More from this programme
Part 1
How do manage patients with multi-vessel disease during PPCI?
Part 2
Do you think we should be doing multi-vessel revascularisation instead of CABG? If so, in which cases?
Part 3
Do you prefer Clopidogrel, Ticagrelor or Prasugrel?
Part 4
Do you have any concerns giving adenosine during PPCI or would your prefer and adenosine-free technique?
Part 5
Do you believe registry (i.e. culprit only) or RCT data (treat all vessels)?
Part 6
Do you believe coronary physiology has a role in non-culprit PPCI decision-making?
Part 7
Are you using G2B3A inhibitors like ReoPro?
Part 8
Are you using Bivalirudin or Heparin?
Part 9
What trials best support the use of MVD PCI?
Part 10
Should we balloon acutely and then returning to stent the following morning?
Part 11
Should PPCI be performed at large surgical centres only?
Faculty Biographies
Keith G Oldroyd
Cardiology Consultant
Keith G. Oldroyd is a British interventional cardiologist whose career has been closely associated with cardiovascular care and research in Scotland. He is based in Glasgow and works at the West of Scotland Regional Heart and Lung Centre at the Golden Jubilee National Hospital. Over several decades, he has combined high-volume clinical practice with academic leadership and internationally recognised cardiovascular research.
Academic History
Professor Oldroyd qualified in medicine from the University of Aberdeen in 1982, earning the degree of MBChB. He later completed doctoral research and was awarded a Doctor of Medicine degree with honours. He is a Fellow of the Royal College of Physicians and Surgeons of Glasgow and a Fellow of the Society for Cardiovascular Angiography and Interventions.
He holds a personal Chair within the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, reflecting his sustained academic…